ASPN
Analyst Note: Aspen Aerogels, Inc. (ASPN)
Date: 2026-06-13 Current Price: $6.32
1. Structural Readiness
- State: Context-only.
- *Classification:* A forming coil is a partial readiness signal. It indicates the structure is intact and price is holding above the invalidation line, but it is not yet actionable on its own. It is distinct from a "Confirmed-Active" state where a breakout has fired.
- Conservative Entry: Not yet triggered (requires confirmed breakout above the coil high).
- Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal; requires confirmation of the breakout.
- Breakout Level: Not yet defined (requires price to close above the coil resistance).
- Current Price: $6.32.
- Extension: Not applicable (price is within the coil structure, not extended above entry).
- ATR Context: Current ATR is 6.4% (Very High). This indicates elevated volatility, which increases the risk of whipsaws during the forming phase but suggests significant potential for a large move if the breakout occurs.
2. Thesis Layer
- Thesis Classification: Tactical / Setup-Led.
- Macro Thesis: There is no named secular thesis attached to this specific setup at this date.
- Judgment Criteria: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals (revenue guidance, operational restart, and margin trajectory). Do not invent a macro narrative; the setup is the primary driver here.
3. Business Overview
Aspen Aerogels, Inc. is a manufacturer of advanced aerogel insulation products serving the energy infrastructure, building materials, and electric vehicle (EV) markets.
- Core Products:
- PyroThin®: Proprietary thermal barriers for lithium-ion battery packs in EVs. The company has entered multi-year production contracts with major OEMs, including GM, with terms extending through 2030–2034 (Evidence E16, E17, E18).
- Energy Infrastructure: Products like Pyrogel XTE, HPS, and Cryogel Z serve LNG, power generation, and cryogenic applications (Evidence E23, E27).
- Building Materials: Spaceloft series for thermal and fire protection (Evidence E28).
- Operational Status (as of June 13, 2026):
- Facility Disruption: An explosion occurred at the East Providence, Rhode Island facility on April 8, 2026. As of May 8, 2026, the facility remained offline (Evidence E12, E13).
- Restart Plan: Management expects a "staged restart" to begin in May 2026, subject to safety and operational reviews (Evidence E1).
- Restructuring: A plan to consolidate automated fabrication operations in Mexico was implemented in Q1 2026 to improve costs (Evidence E14).
- Financial Performance (Q1 2026):
- Revenue: Q1 EU thermal barrier revenue increased more than threefold year-over-year.
- Guidance: Management expects Q2 2026 revenue between $40 million and $48 million, with increased profitability relative to Q1 (Evidence E6).
- Full Year Outlook: Despite the "messy start" due to the EP disruption, management maintains a target of 20% revenue growth for 2026 (Evidence E2).
- Losses: The company reported a net loss of $23.7 million for the three months ended March 31, 2026, though it generated $34.1 million in cash from operations (Evidence E15).
- Subsea & LNG: The company was awarded a second subsea project deliverable in Q3 2025, positioning it for $10M–$20M in annual revenue from this segment in 2026 (Evidence E3). Management expects LNG-related activity to approximately double in 2026 versus 2025 (Evidence E4).
4. Archetype and Conviction
- Archetype: Growth Leader (with elements of a Cyclical Recovery).
- *Fit:* The company is positioned in high-growth sectors (EV thermal management, global energy infrastructure) with multi-year contracts. However, the current setup is heavily influenced by a specific operational recovery (post-explosion restart) and cost restructuring, creating a "recovery" dynamic within a growth framework.
- Valuation Context:
- Forward consensus EPS for FY1 is -0.7725 and FY2 is -0.12 (Evidence E29). The company is currently unprofitable on a GAAP basis, relying on operational cash flow ($34.1M in Q1) to fund the turnaround.
- Conviction Stack:
- Thesis Strength: Low (No named macro thesis; purely tactical).
- Evidence Quality: High. Management has provided specific, quantified guidance on revenue ($40M–$48M for Q2), growth targets (20% for FY), and specific contract terms (GM contracts through 2034).
- Setup Readiness: Partial. The setup is "Forming," meaning it is a watch-list candidate but not yet a confirmed entry.
- Rerating Potential: High, contingent on the successful execution of the facility restart and the realization of the 20% revenue growth target.
5. Invalidations, Strengths, and Gaps
- What Would Invalidate:
- Failure to execute the "staged restart" by management's stated timeline (post-May 2026).
- Significant delay in the Mexico consolidation or further operational disruptions at East Providence.
- What Would Strengthen:
- A confirmed breakout above the coil resistance (price action).
- Confirmation of the Q2 revenue guidance ($40M–$48M) in the upcoming earnings report.
- Positive updates on the subsea project delivery or new EV contract wins.
- Gaps in Evidence:
- Breakout Level: The specific resistance level required for a confirmed breakout is not defined.
- Cash Runway: While Q1 cash flow is positive, the long-term cash runway given the $23.7M quarterly loss and capex needs is not explicitly detailed beyond the current period.
PRIVATE ANALYST CALL
Judgment: Speculative Confidence: medium Key evidence: Management guidance for 20% revenue growth in 2026 despite facility disruption; multi-year GM contracts extending to 2034; Q1 cash flow of $34.1M offsetting net loss. Key risks: East Providence facility restart delays; very high ATR (6.4%) indicating elevated volatility and potential for whipsaws; continued GAAP losses with negative forward EPS. Sizing hint: Position size should be reduced relative to a confirmed breakout setup due to the "forming" status and high volatility. Expected path: Price consolidates within the forming coil structure while management executes the facility restart and delivers Q2 revenue within the $40M-$48M guidance range. Expected horizon: 3 to 6 months for the setup to resolve into a confirmed breakout or invalidation.
Chart
Evidence & Catalysts
Source-backed evidence anchors and catalysts land once Convexity finishes coverage for ASPN.
Core Assumptions
Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.
Value Picture
Value picture unavailable — no financial spine on file for ASPN.
Financial Highlights
Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.